Versant Venture Management’s BIOTIE THERAPIES CORP SPONSORED ADR BITI Stock Holding History

Versant Venture Management’s Portfolio BITI Stock Details BITI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-268,672	Closed	-$7.09M	–	7
2016 Q1	$7.09M	Hold	268,672	–	–	5.12%	5
2015 Q4	$3.86M	Hold	268,672	–	–	2.26%	6
2015 Q3	$3.52M	Hold	268,672	–	–	2.02%	6
2015 Q2	$5.37M	Buy	+268,672	New	+$5.61M	6.81%	4

Versant Venture Management's BITI Position: Q2 2016 in Review

Versant Venture Management sold out of BIOTIE THERAPIES CORP SPONSORED ADR (BITI) in Q2 2016, closing a stake of 268,672 shares — an estimated $7.09M sold.

Versant Venture Management first reported a position in BITI in Q2 2015 and held it in 4 quarters. The position peaked at $7.09M in Q1 2016. 0 funds tracked by Wall St. Rank hold BITI as of Q2 2016.

Versant Venture Management reported no remaining BIOTIE THERAPIES CORP SPONSORED ADR position as of Q2 2016 after selling out during the quarter.
Versant Venture Management sold 268,672 BIOTIE THERAPIES CORP SPONSORED ADR shares in Q2 2016, an estimated $7.09M.
Versant Venture Management first reported a position in BIOTIE THERAPIES CORP SPONSORED ADR in Q2 2015 and held it in 4 quarters.
Versant Venture Management's BIOTIE THERAPIES CORP SPONSORED ADR position peaked at $7.09M in Q1 2016.
0 funds tracked by Wall St. Rank held BIOTIE THERAPIES CORP SPONSORED ADR as of Q2 2016.

Based on Versant Venture Management's 13F filing for Q2 2016, filed 28 Jul 2016.